BostonGene and Exigent Genomic INsight Study
The BEGIN Study by BostonGene and Exigent Genomic INsight evaluates the efficacy of comprehensive molecular testing in advanced cancer patients. Using the BostonGene Tumor Portrait test, the study aims to identify actionable findings, assess feasibility, and determine patient enrollment in clinical trials. Four cohorts of 100 patients each will be studied over two years, focusing on treatment decisions and patient outcomes. This study seeks to demonstrate the clinical utility of genomic testing in guiding therapy for advanced cancer patients in community settings.
Checked against the public recordLast updated Feb 17, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- BostonGene
- Interventions being studied
- Not specified
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Patients must have a confirmed malignancy of: Locally recurrent, unresectable, or metastatic breast cancer or; Unresectable stage III or metastatic non-small cell lung cancer or; Unresectable or metastatic melanoma or; Locally advanced or metastatic l sarcoma. * Life expectancy \> 3 months as per the treating physician * Willingness to provide informed consent * Living in the United States at time of enrollment * Agree to participate in genomic and molecular profiling Exclusion Criteria: * not meeting the inclusion criteria
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Highlands Oncology GroupRogers, Arkansas
- Stockton Hematology Oncology Medical GroupStockton, California
- Fort Wayne Medical Oncology and HematologyFort Wayne, Indiana
- New Mexico Cancer CenterAlbuquerque, New Mexico
- Oklahoma Cancer Specialists and Research InstituteTulsa, Oklahoma
- Oncology ConsultantsHouston, Texas
- Northwest Medical SpecialitiesPuyallup, Washington
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 17, 2025. Always confirm current availability with the study team.